Skip to main content
. 2020 Jun 20;44:102310. doi: 10.1016/j.msard.2020.102310

Fig. 3.

Fig. 3:

Treatment initiation in MS and NMOSD patients. Analysis of decision-making in treatment continuation in MS (A) and NMOSD (B) patients without COVID-19.